STOCK TITAN

[Form 4] DENTSPLY SIRONA Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. (ticker XRAY) filed a Form 4 reporting that Executive Vice President, Corporate Development, General Counsel & Secretary Richard C. Rosenzweig modestly increased his equity stake on 07/11/2025.

  • 595.34 additional common shares were credited to him as dividend equivalents on previously granted restricted stock units (RSUs). The shares carry the same vesting schedule as the underlying RSUs and were recorded at $0 cost.
  • Following the transaction, Rosenzweig directly owns 84,417.217 common shares.
  • He also received 59.2766 phantom stock units under the company’s Supplemental Executive Retirement Plan (SERP), bringing his total phantom balance to 6,062.0133 units. Each unit is the economic equivalent of one common share and becomes payable in stock upon termination of employment.

No shares were disposed of, and the filing cites automatic dividend reinvestment rather than discretionary open-market purchases. The document was signed on 07/15/2025 by attorney-in-fact Jessica Causey.

DENTSPLY SIRONA Inc. (simbolo XRAY) ha presentato un Modulo 4 segnalando che il Vice Presidente Esecutivo, Sviluppo Aziendale, Consigliere Generale e Segretario Richard C. Rosenzweig ha aumentato leggermente la sua partecipazione azionaria il 11/07/2025.

  • Gli sono state accreditate 595,34 azioni ordinarie aggiuntive come equivalenti di dividendi su unità azionarie vincolate (RSU) precedentemente assegnate. Le azioni seguono lo stesso calendario di maturazione delle RSU sottostanti e sono state registrate a costo zero.
  • Dopo la transazione, Rosenzweig possiede direttamente 84.417,217 azioni ordinarie.
  • Ha inoltre ricevuto 59,2766 unità azionarie fantasma nell’ambito del Piano Supplementare di Pensionamento Esecutivo (SERP) della società, portando il suo totale a 6.062,0133 unità fantasma. Ogni unità equivale economicamente a un’azione ordinaria e diventa pagabile in azioni al termine del rapporto di lavoro.

Non sono state cedute azioni e il documento indica un reinvestimento automatico dei dividendi anziché acquisti discrezionali sul mercato aperto. Il documento è stato firmato il 15/07/2025 dall’avvocato delegato Jessica Causey.

DENTSPLY SIRONA Inc. (símbolo bursátil XRAY) presentó un Formulario 4 informando que el Vicepresidente Ejecutivo, Desarrollo Corporativo, Asesor General y Secretario Richard C. Rosenzweig incrementó modestamente su participación accionaria el 11/07/2025.

  • Se le acreditaron 595,34 acciones ordinarias adicionales como equivalentes de dividendos sobre unidades restringidas de acciones (RSU) previamente otorgadas. Las acciones tienen el mismo calendario de consolidación que las RSU subyacentes y se registraron a un costo de $0.
  • Tras la transacción, Rosenzweig posee directamente 84.417,217 acciones ordinarias.
  • También recibió 59,2766 unidades fantasma bajo el Plan Suplementario de Retiro Ejecutivo (SERP) de la empresa, sumando un total de 6.062,0133 unidades fantasma. Cada unidad equivale económicamente a una acción ordinaria y se paga en acciones al terminar la relación laboral.

No se dispusieron acciones y el informe menciona reinversión automática de dividendos en lugar de compras discrecionales en el mercado abierto. El documento fue firmado el 15/07/2025 por la apoderada Jessica Causey.

DENTSPLY SIRONA Inc. (티커 XRAY)는 2025년 7월 11일에 임원 부사장 겸 기업 개발 담당, 법률 고문 및 비서인 Richard C. Rosenzweig가 자신의 지분을 소폭 늘렸음을 보고하는 Form 4를 제출했습니다.

  • 기존에 부여된 제한 주식 단위(RSU)에 대한 배당금 상응분으로 595.34주의 보통주가 추가로 지급되었습니다. 이 주식들은 기본 RSU와 동일한 권리 확정 일정이 적용되며 비용 $0으로 기록되었습니다.
  • 거래 후 Rosenzweig는 직접 84,417.217주의 보통주를 보유하게 되었습니다.
  • 또한 회사의 추가 임원 퇴직연금 계획(SERP)에 따라 59.2766 단위의 팬텀 스톡 유닛을 받았으며, 총 팬텀 잔액은 6,062.0133 단위가 되었습니다. 각 단위는 1주 보통주의 경제적 가치와 같으며 고용 종료 시 주식으로 지급됩니다.

주식 처분은 없었으며, 제출서류에는 임의의 공개시장 매입이 아닌 자동 배당 재투자가 명시되어 있습니다. 문서는 2025년 7월 15일 대리인 Jessica Causey가 서명했습니다.

DENTSPLY SIRONA Inc. (symbole XRAY) a déposé un formulaire 4 indiquant que le vice-président exécutif, développement corporatif, conseiller juridique général et secrétaire Richard C. Rosenzweig a légèrement augmenté sa participation en actions le 11/07/2025.

  • 595,34 actions ordinaires supplémentaires lui ont été attribuées sous forme d’équivalents de dividendes sur des unités d’actions restreintes (RSU) précédemment accordées. Ces actions suivent le même calendrier d’acquisition que les RSU sous-jacentes et ont été enregistrées à coût nul.
  • Après la transaction, Rosenzweig détient directement 84 417,217 actions ordinaires.
  • Il a également reçu 59,2766 unités d’actions fantômes dans le cadre du Plan de Retraite Supplémentaire des Dirigeants (SERP) de la société, portant son solde total d’unités fantômes à 6 062,0133. Chaque unité équivaut économiquement à une action ordinaire et devient payable en actions à la fin de son emploi.

Aucune action n’a été cédée, et le dépôt mentionne un réinvestissement automatique des dividendes plutôt que des achats discrétionnaires sur le marché ouvert. Le document a été signé le 15/07/2025 par la mandataire Jessica Causey.

DENTSPLY SIRONA Inc. (Ticker XRAY) reichte ein Formular 4 ein, in dem berichtet wird, dass der Executive Vice President für Unternehmensentwicklung, General Counsel und Sekretär Richard C. Rosenzweig am 11.07.2025 seinen Aktienanteil geringfügig erhöht hat.

  • Ihm wurden 595,34 zusätzliche Stammaktien als Dividendenäquivalente auf zuvor gewährte Restricted Stock Units (RSUs) gutgeschrieben. Die Aktien unterliegen dem gleichen Vesting-Zeitplan wie die zugrunde liegenden RSUs und wurden mit 0 $ Kosten verbucht.
  • Nach der Transaktion besitzt Rosenzweig direkt 84.417,217 Stammaktien.
  • Er erhielt außerdem 59,2766 Phantomaktieneinheiten im Rahmen des ergänzenden Executive Retirement Plans (SERP) des Unternehmens, womit sein gesamtes Phantomguthaben auf 6.062,0133 Einheiten anstieg. Jede Einheit entspricht wirtschaftlich einer Stammaktie und wird bei Beendigung des Arbeitsverhältnisses in Aktien ausgezahlt.

Es wurden keine Aktien veräußert, und in der Meldung wird auf eine automatische Wiederanlage der Dividenden statt auf diskretionäre Käufe am freien Markt hingewiesen. Das Dokument wurde am 15.07.2025 von der Bevollmächtigten Jessica Causey unterzeichnet.

Positive
  • Insider’s direct common share holdings rose by 595.34 shares, reflecting continued equity alignment.
  • No shares were sold, preserving long-term insider ownership.
Negative
  • The acquisitions were automatic dividend equivalents, limiting their signaling value to investors.
  • Transaction size is immaterial relative to the executive’s existing stake and company float.

Insights

TL;DR — Small, automatic dividend RSU credits; neutral to mildly positive signal.

The filing shows a routine credit of 595.34 RSU dividend shares and 59.2766 SERP phantom units to a senior executive. Because the transactions stem from dividend reinvestment rather than open-market buying, the informational value is low. Still, the absence of sales keeps insider sentiment neutral-to-positive, reinforcing alignment with shareholders. Size is immaterial versus both Rosenzweig’s 84k-share stake and XRAY’s ~215 m share float, so market impact should be negligible.

TL;DR — Governance-friendly: no disposals, equity exposure maintained.

From a governance standpoint, dividend reinvestment into RSUs and phantom stock keeps management incentives equity-linked and long-dated. Such mechanisms strengthen pay-for-performance structures without immediate dilution or cash cost. Because the shares vest with the original awards, they maintain existing clawback and forfeiture provisions. However, investors should not interpret the credits as an active expression of confidence, as they are automatic.

DENTSPLY SIRONA Inc. (simbolo XRAY) ha presentato un Modulo 4 segnalando che il Vice Presidente Esecutivo, Sviluppo Aziendale, Consigliere Generale e Segretario Richard C. Rosenzweig ha aumentato leggermente la sua partecipazione azionaria il 11/07/2025.

  • Gli sono state accreditate 595,34 azioni ordinarie aggiuntive come equivalenti di dividendi su unità azionarie vincolate (RSU) precedentemente assegnate. Le azioni seguono lo stesso calendario di maturazione delle RSU sottostanti e sono state registrate a costo zero.
  • Dopo la transazione, Rosenzweig possiede direttamente 84.417,217 azioni ordinarie.
  • Ha inoltre ricevuto 59,2766 unità azionarie fantasma nell’ambito del Piano Supplementare di Pensionamento Esecutivo (SERP) della società, portando il suo totale a 6.062,0133 unità fantasma. Ogni unità equivale economicamente a un’azione ordinaria e diventa pagabile in azioni al termine del rapporto di lavoro.

Non sono state cedute azioni e il documento indica un reinvestimento automatico dei dividendi anziché acquisti discrezionali sul mercato aperto. Il documento è stato firmato il 15/07/2025 dall’avvocato delegato Jessica Causey.

DENTSPLY SIRONA Inc. (símbolo bursátil XRAY) presentó un Formulario 4 informando que el Vicepresidente Ejecutivo, Desarrollo Corporativo, Asesor General y Secretario Richard C. Rosenzweig incrementó modestamente su participación accionaria el 11/07/2025.

  • Se le acreditaron 595,34 acciones ordinarias adicionales como equivalentes de dividendos sobre unidades restringidas de acciones (RSU) previamente otorgadas. Las acciones tienen el mismo calendario de consolidación que las RSU subyacentes y se registraron a un costo de $0.
  • Tras la transacción, Rosenzweig posee directamente 84.417,217 acciones ordinarias.
  • También recibió 59,2766 unidades fantasma bajo el Plan Suplementario de Retiro Ejecutivo (SERP) de la empresa, sumando un total de 6.062,0133 unidades fantasma. Cada unidad equivale económicamente a una acción ordinaria y se paga en acciones al terminar la relación laboral.

No se dispusieron acciones y el informe menciona reinversión automática de dividendos en lugar de compras discrecionales en el mercado abierto. El documento fue firmado el 15/07/2025 por la apoderada Jessica Causey.

DENTSPLY SIRONA Inc. (티커 XRAY)는 2025년 7월 11일에 임원 부사장 겸 기업 개발 담당, 법률 고문 및 비서인 Richard C. Rosenzweig가 자신의 지분을 소폭 늘렸음을 보고하는 Form 4를 제출했습니다.

  • 기존에 부여된 제한 주식 단위(RSU)에 대한 배당금 상응분으로 595.34주의 보통주가 추가로 지급되었습니다. 이 주식들은 기본 RSU와 동일한 권리 확정 일정이 적용되며 비용 $0으로 기록되었습니다.
  • 거래 후 Rosenzweig는 직접 84,417.217주의 보통주를 보유하게 되었습니다.
  • 또한 회사의 추가 임원 퇴직연금 계획(SERP)에 따라 59.2766 단위의 팬텀 스톡 유닛을 받았으며, 총 팬텀 잔액은 6,062.0133 단위가 되었습니다. 각 단위는 1주 보통주의 경제적 가치와 같으며 고용 종료 시 주식으로 지급됩니다.

주식 처분은 없었으며, 제출서류에는 임의의 공개시장 매입이 아닌 자동 배당 재투자가 명시되어 있습니다. 문서는 2025년 7월 15일 대리인 Jessica Causey가 서명했습니다.

DENTSPLY SIRONA Inc. (symbole XRAY) a déposé un formulaire 4 indiquant que le vice-président exécutif, développement corporatif, conseiller juridique général et secrétaire Richard C. Rosenzweig a légèrement augmenté sa participation en actions le 11/07/2025.

  • 595,34 actions ordinaires supplémentaires lui ont été attribuées sous forme d’équivalents de dividendes sur des unités d’actions restreintes (RSU) précédemment accordées. Ces actions suivent le même calendrier d’acquisition que les RSU sous-jacentes et ont été enregistrées à coût nul.
  • Après la transaction, Rosenzweig détient directement 84 417,217 actions ordinaires.
  • Il a également reçu 59,2766 unités d’actions fantômes dans le cadre du Plan de Retraite Supplémentaire des Dirigeants (SERP) de la société, portant son solde total d’unités fantômes à 6 062,0133. Chaque unité équivaut économiquement à une action ordinaire et devient payable en actions à la fin de son emploi.

Aucune action n’a été cédée, et le dépôt mentionne un réinvestissement automatique des dividendes plutôt que des achats discrétionnaires sur le marché ouvert. Le document a été signé le 15/07/2025 par la mandataire Jessica Causey.

DENTSPLY SIRONA Inc. (Ticker XRAY) reichte ein Formular 4 ein, in dem berichtet wird, dass der Executive Vice President für Unternehmensentwicklung, General Counsel und Sekretär Richard C. Rosenzweig am 11.07.2025 seinen Aktienanteil geringfügig erhöht hat.

  • Ihm wurden 595,34 zusätzliche Stammaktien als Dividendenäquivalente auf zuvor gewährte Restricted Stock Units (RSUs) gutgeschrieben. Die Aktien unterliegen dem gleichen Vesting-Zeitplan wie die zugrunde liegenden RSUs und wurden mit 0 $ Kosten verbucht.
  • Nach der Transaktion besitzt Rosenzweig direkt 84.417,217 Stammaktien.
  • Er erhielt außerdem 59,2766 Phantomaktieneinheiten im Rahmen des ergänzenden Executive Retirement Plans (SERP) des Unternehmens, womit sein gesamtes Phantomguthaben auf 6.062,0133 Einheiten anstieg. Jede Einheit entspricht wirtschaftlich einer Stammaktie und wird bei Beendigung des Arbeitsverhältnisses in Aktien ausgezahlt.

Es wurden keine Aktien veräußert, und in der Meldung wird auf eine automatische Wiederanlage der Dividenden statt auf diskretionäre Käufe am freien Markt hingewiesen. Das Dokument wurde am 15.07.2025 von der Bevollmächtigten Jessica Causey unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
ROSENZWEIG RICHARD C

(Last) (First) (Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE

(Street)
CHARLOTTE NC 28277

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Corp Dev, GC & Secretary
3. Date of Earliest Transaction (Month/Day/Year)
07/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/11/2025 A 595.34(1) A $0 84,417.217(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock (Supplemental Executive Retirement Plan) SERP (3) 07/11/2025 A 59.2766(4) (3) (3) Common Stock 59.2766 $16.2 6,062.0133 D
Explanation of Responses:
1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
2. Includes 370 shares acquired between January 1st - June 30, 2025 under the Dentsply Sirona Employee Stock Purchase Plan.
3. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.
4. Comprised of phantom stock acquired as a result of accrued dividends.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Jessica Causey, Attorney-In-Fact for Richard C. Rosenzweig 07/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many DENTSPLY SIRONA (XRAY) shares did Richard C. Rosenzweig acquire?

595.34 common shares were credited as dividend equivalents on 07/11/2025.

Did the executive sell any XRAY shares in this Form 4?

No. The filing reports only acquisitions; no dispositions occurred.

What is the executive’s total direct XRAY share ownership after the transaction?

Rosenzweig now directly owns 84,417.217 common shares.

What are phantom stock units mentioned in the filing?

Phantom units are SERP credits economically equal to one common share, payable in stock upon employment termination.

Is this insider activity likely to impact XRAY’s stock price?

Given the small, automatic nature of the transaction, market impact is expected to be minimal.
Dentsply Sirona Inc

NASDAQ:XRAY

XRAY Rankings

XRAY Latest News

XRAY Latest SEC Filings

XRAY Stock Data

3.29B
198.48M
0.45%
106.2%
4.05%
Medical Instruments & Supplies
Dental Equipment & Supplies
Link
United States
CHARLOTTE